What is the evidence that ecstasy (MDMA) can cause Parkinson's disease?

被引：24
作者：
Kish, SJ [1 ]
机构：
[1] Ctr Addict & Mental Hlth, Human Neurochem Pathol Lab, Toronto, ON, Canada
来源：
MOVEMENT DISORDERS | 2003年 / 18卷 / 11期
关键词：
D O I：
10.1002/mds.10643
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1219 / 1223
页数：5
相关论文
共 27 条
  • [1] BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911
  • [2] Buchert R, 2003, J NUCL MED, V44, P375
  • [3] COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338
  • [4] Kalant H, 2001, CAN MED ASSOC J, V165, P917
  • [5] The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens
    Kankaanpää, A
    Meririnne, E
    Lillsunde, P
    Seppälä, T
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (04) : 1003 - 1009
  • [6] Expedited publication - Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user
    Kish, SJ
    Furukawa, Y
    Ang, L
    Vorce, SP
    Kalasinsky, KS
    [J]. NEUROLOGY, 2000, 55 (02) : 294 - 296
  • [7] How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
    Kish, SJ
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) : 845 - 855
  • [8] MDMA and parkinsonism
    Kuniyoshi, SM
    Jankovic, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) : 96 - 97
  • [9] Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans
    Liechti, ME
    Vollenweider, FX
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2000, 10 (04) : 289 - 295
  • [10] Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
    Liechti, ME
    Saur, MR
    Gamma, A
    Hell, D
    Vollenweider, FX
    [J]. NEUROPSYCHOPHARMACOLOGY, 2000, 23 (04) : 396 - 404
123